Unique ID issued by UMIN | UMIN000001195 |
---|---|
Receipt number | R000000960 |
Scientific Title | Joint repair using an in vitro generated scaffold-free tissue engineerd construct (TEC) derived from autologous synovial mesenchymal stem cells |
Date of disclosure of the study information | 2008/07/01 |
Last modified on | 2012/06/18 16:51:28 |
Joint repair using an in vitro generated scaffold-free tissue engineerd construct (TEC) derived from autologous synovial mesenchymal stem cells
Joint repair by tissue engineerd construct (TEC)
Joint repair using an in vitro generated scaffold-free tissue engineerd construct (TEC) derived from autologous synovial mesenchymal stem cells
Joint repair by tissue engineerd construct (TEC)
Japan |
Chondral lesions
Meniscal lesions
Orthopedics |
Others
NO
The objective is to evaluate the feasibility ofin vitro generated mesenchymal stem cell (MSC)-based tissue engineered construct (TEC) to intra-articular lesions.
Safety,Efficacy
Exploratory
Explanatory
Phase I,II
Adverse events (National Cancer Institute-Common Toxicity; NCI-CTC; version 2, JACOG version)
Arthoscopic assessment of repaired tissue using ICRS evaluation package (http://www.cartilage.org) for chondral lesions and Horibe score (J Bone Joint Surg Br. 1995; 77:245-9) for meniscal lesions.
Periodical assessment of clinical symptoms, evaluation by MRI, histology, activity scales (Lyshlom, Tegnar), and by overall subjective assessment score (Knee Injury and Osteoarthritis Outcome Score; KOOS)
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Device,equipment | Maneuver |
Implantation of in vitro generated mesenchymal stem cell (MSC)-based tissue engineered construct (TEC) to chondral or meniscal lesions of the knee.
15 | years-old | <= |
60 | years-old | > |
Male and Female
Patients with a symptomatic (including pain, catching, locking, or joint effusion) chondral or meniscal lesion of the knee which is clinically detectable by MRI
Patients with
1) Active local infection
2) Serious complications including malignancies
3) Alchol or drung abuse
4) Rheumatoid arthritis, gout, or pseudo gout
5) Abnormal alignment of lower extremity
6) Chondral lesion with more than 5cm2
7) Meniscal lesion with large defect more than one-third of whole meniscal body
8) Patello-femoral instability
9) Diabetes
10) Renal failure which requires dialysis
11) the medication which could affect chondral metabolosm such as vitamin C or hyaluronan
12) Infectious disease (HIV, HBV, HCV, HTLV, syphilis)
13) Pregnancy
14) Allergy
15) participation in other clinical trials
16)Judged inappropriate with other reason by the project investigators
20
1st name | |
Middle name | |
Last name | Hideki Yoshikawa |
Osaka University Graduate School of Medicine
Department of orthopaedics
2-2, yamada-oka, Suita, Osaka, 565-0871, Japan
06-6879-3552
1st name | |
Middle name | |
Last name | Norimasa Nakamura |
Osaka University
Center for Advanced Medical Engineering and Informatics
2-2, yamada-oka, Suita, Osaka, 565-0871, Japan
06-6879-3552
Department of orthopaedics, Osaka University Graduate School of Medicine
None
Self funding
Osaka University Hospital, Medical center for translational Research
NO
2008 | Year | 07 | Month | 01 | Day |
Unpublished
Terminated
2009 | Year | 10 | Month | 10 | Day |
2009 | Year | 12 | Month | 01 | Day |
2012 | Year | 02 | Month | 01 | Day |
2008 | Year | 06 | Month | 17 | Day |
2012 | Year | 06 | Month | 18 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000960